To confirm a diagnosis and determine the stage of the disease, your doctor will use a series of tests: Biopsy: This is the most definitive test. A surgeon will remove all or part of an affected lymph ...

In the global intention-to-treat population, Pola-R-CHP showed significant progression-free survival benefit over R-CHOP ...

Lymphoma is a type of cancer that affects the lymphatic system, a vital part of the immune system. For individuals facing this diagnosis, understanding the range of treatment options available can be ...

Over the past decade, there has been a significant increase in the number of approved drugs for treating lymphoma. Before the ...

Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma whose diagnosis relies on integrated clinical, pathological, and imaging assessments. Established diagnostic criteria include ...

Hodgkin’s lymphoma is rapidly expanding, driven by innovative clinical advancements and the pressing need for effective treatments in relapsed cases. Affecting over 500,000 individuals annually, ...

Stage 2 Hodgkin’s lymphoma is an early stage of this cancer. Healthcare professionals describe Hodgkin’s lymphoma as stage 2 when a person has cancer in two or more lymph node groups, either below or ...

Al Unger beat aggressive lymphoma through personalized treatment, proving age doesn't limit cancer recovery with the right ...

The global Cutaneous T-cell Lymphoma (CTCL) market is witnessing significant growth due to increasing disease prevalence, particularly among older populations, and advancements in diagnostic ...

After undergoing treatment for Stage 2 Hodgkins lymphoma, Hardee Bhavsar is on a journey to cross items off her bucket list which include visiting dream travel destinations and running in the New York ...